The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N4-([1,1'-biphenyl]-4-yl)-N2-(2-(piperidin-1-yl)ethyl)pyrimidine-2,4-diamine ID: ALA4520099
PubChem CID: 155542066
Max Phase: Preclinical
Molecular Formula: C23H27N5
Molecular Weight: 373.50
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc(-c2ccc(Nc3ccnc(NCCN4CCCCC4)n3)cc2)cc1
Standard InChI: InChI=1S/C23H27N5/c1-3-7-19(8-4-1)20-9-11-21(12-10-20)26-22-13-14-24-23(27-22)25-15-18-28-16-5-2-6-17-28/h1,3-4,7-14H,2,5-6,15-18H2,(H2,24,25,26,27)
Standard InChI Key: YJVYVIVOOWNUAK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
32.1084 -11.7007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1073 -12.5202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8153 -12.9292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5250 -12.5197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5222 -11.6971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.8135 -11.2918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2333 -12.9272 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.9404 -12.5175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6487 -12.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3558 -12.5153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.0608 -12.9271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7658 -12.5209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7687 -11.7034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0605 -11.2937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3494 -11.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8111 -10.4746 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.1022 -10.0681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1031 -9.2517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3950 -8.8453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6875 -9.2560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6926 -10.0774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4012 -10.4801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9815 -8.8522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9793 -8.0339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2706 -7.6285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5637 -8.0402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5699 -8.8616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2791 -9.2633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
6 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
20 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.50Molecular Weight (Monoisotopic): 373.2266AlogP: 4.79#Rotatable Bonds: 7Polar Surface Area: 53.08Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.42CX LogP: 4.75CX LogD: 3.69Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.62Np Likeness Score: -1.43
References 1. Leal ES, Adler NS, Fernández GA, Gebhard LG, Battini L, Aucar MG, Videla M, Monge ME, Hernández de Los Ríos A, Acosta Dávila JA, Morell ML, Cordo SM, García CC, Gamarnik AV, Cavasotto CN, Bollini M.. (2019) De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus., 182 [PMID:31472473 ] [10.1016/j.ejmech.2019.111628 ] 2. De S, Aamna B, Sahu R, Parida S, Behera SK, Dan AK.. (2022) Seeking heterocyclic scaffolds as antivirals against dengue virus., 240 [PMID:35816877 ] [10.1016/j.ejmech.2022.114576 ]